ON THE QUESTION OF THE SAFETY OF A 4-ALKYL-SUBSTITUTED COMPOUND WITH ANTI-TUMOUR ACTION

Marina Dudina(Sechenov University), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Elena A. Samyshina, I. Ya. Moiseeva(Penza State University), Екатерина Блинова(Sechenov University), И. Р. Суслова
Кубанский научный медицинский вестник
March 13, 2019
10.25207/1608-6228-2019-26-1-101-107
Cited by 1

Related Papers

Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13